Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Anti-tumoral and anti-inflammatory effects of biological stains (CROSBI ID 178192)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Culo, F ; Sabolović, Domagoj ; Somogyi, Lehel ; Marusić, Matko ; Berbiguier, N ; Galey, L Anti-tumoral and anti-inflammatory effects of biological stains // Agents and actions, 34 (1991), 3/4; 424-428

Podaci o odgovornosti

Culo, F ; Sabolović, Domagoj ; Somogyi, Lehel ; Marusić, Matko ; Berbiguier, N ; Galey, L

engleski

Anti-tumoral and anti-inflammatory effects of biological stains

The biological stains, methylene blue and its metabolite azure B, were evaluated as anti-tumor and anti-inflammatory agents. Azur B, administered in drinking water to tumor-bearing mice, inhibited the growth of transplanted tumors and the growth of primary tumors induced by methylcholanthrene. Inhibition of growth of primary tumors was observed only in female mice. Azure B also reduced the wet weight of carrageenin-induced granulomas in rats. Azure B, given intravenously to BCG-sensitized mice 15 minutes prior to challenge with lipopolysaccharide, decreased TNF production (to 10% of control values) and prevented death from endotoxic shock. Methylene blue decreased TNF production (to 50% of control values) but did not protect the animals from endotoxic shock. Our results suggest that some of the effects previously ascribed to methylene blue are probably mediated via its metabolite, i.e. azure B. Low toxicity and easy administration of the dyes explain their use in clinical settings

growth of malinant tumors; ature A; AzureB; BCG; TNF-alpha

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

34 (3/4)

1991.

424-428

objavljeno

0065-4299

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost